Week of Study | ||||||||
---|---|---|---|---|---|---|---|---|
0 | 1 | 4 | 8 | 9 | 10 | 12 | p-valueb | |
CK, IU/L | ||||||||
Placebo | 141 ± 12 | 582 ± 77 | 373 ± 13 | 246 ± 29 | 484 ± 52 | 528 ± 72 | 187 ± 21 | |
ATP | 145 ± 8 | 500 ± 71 | 324 ± 14 | 234 ± 32 | 426 ± 44 | 449 ± 62 | 160 ± 20 | 0.91 |
24 h 3MH:Cr, μmol:mg | ||||||||
Placebo | 0.127 ± 0.007 | 0.130 ± 0.003 | Nmc | 0.123 ± 0.004 | 0.134 ± 0.005 | 0.152 ± 0.005 | Nm | |
ATP | 0.136 ± 0.008 | 0.127 ± 0.007 | Nm | 0.143 ± 0.007# | 0.143 ± 0.008 | 0.131 ± 0.012# | Nm | 0.007 |
CRP, mg/L | ||||||||
Placebo | 1.9 ± 0.7 | 1.1 ± 0.1 | 1.3 ± 0.3 | 2.0 ± 0.7 | 1.6 ± 0.7 | 1.2 ± 0.2 | 1.6 ± 0.4 | |
ATP | 1.4 ± 0.4 | 1.1 ± 0.1 | 1.2 ± 0.2 | 1.9 ± 0.6 | 1.7 ± 0.6 | 1.1 ± 0.1 | 1.2 ± 0.2 | 0.99 |
Cortisol, μg/dL | ||||||||
Placebo | 19.7 ± 1.1 | 20.8 ± 1.3 | 19.0 ± 1.2 | 19.2 ± 0.4 | 22.0 ± 0.4 | 23.6 ± 0.3 | 20.3 ± 0.6 | |
ATP | 20.9 ± 1.2 | 20.5 ± 1.3 | 18.4 ± 1.4 | 19.0 ± 0.4 | 21.5 ± 0.4 | 22.6 ± 0.2 | 19.7 ± 0.6 | 0.86 |
Free Testosterone, ng/dL | ||||||||
Placebo | 103 ± 13 | 112 ± 10 | 119 ± 6 | 111 ± 9 | 98 ± 6 | 100 ± 9 | 113 ± 12 | |
ATP | 112 ± 13 | 114 ± 9 | 118 ± 6 | 117 ± 11 | 108 ± 7 | 110 ± 10 | 125 ± 13 | 0.93 |
Total Testosterone, ng/dL | ||||||||
Placebo | 591 ± 73 | 620 ± 58 | 625 ± 55 | 585 ± 58 | 551 ± 46 | 536 ± 88 | 605 ± 72 | |
ATP | 660 ± 67 | 645 ± 54 | 695 ± 60 | 645 ± 60 | 621 ± 49 | 592 ± 84 | 673 ± 69 | 0.83 |
PRSd | ||||||||
Placebo | 9.1 ± 0.3 | 4.7 ± 0.4 | 7.0 ± 0.3 | 7.6 ± 0.2 | 4.8 ± 0.3 | 4.4 ± 0.3 | 7.6 ± 0.2 | |
ATP | 9.6 ± 0.2 | 4.9 ± 0.4 | 7.5 ± 0.3 | 8.2 ± 0.3 | 5.5 ± 0.4 | 5.5 ± 0.4 | 8.6 ± 0.4 | 0.61 |